TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07834684: Singula Phase 0.1 Primary Care Pilot

Sponsor: Singula Health, Inc. · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 100 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$12,416,000

Rescue Site Savings

+$8,186,800

Unlock Full NCT07834684 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07834684 Rescue Dossier →